Incremental analysis
| Test | Comparator | Incremental outcome | |
| Model 1: CBCT-NB versus TTNB | |||
| Procedure | CBCT-NB | TTNB | |
| Costs (€) | 17 561 | 17 103 | +458 |
| Effect (QALY) | 6.853 | 6.829 | +0.024 |
| ICER (€/QALY) | Cost-effective | 18 416 | |
| Model 2: CBCT-NB versus direct treatment strategy | |||
| Procedure | CBCT-NB | Direct treatment | |
| Costs (€) | 17 561 | 18 845 | −1284 |
| Effect (QALY) | 6.853 | 6.752 | +0.101 |
| ICER (€/QALY) | Dominant | x | |
CBCT-NB, cone beam CT-guided navigation bronchoscopy; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life year; TTNB, transthoracic needle biopsy.